Friday, August 28, 2026

North Korea’s Flood Crisis: Kim Jong Un on the Front Lines of Rescue Efforts

Kim Jong Un personally directed the rescue and evacuation efforts for thousands of residents stranded due to severe flooding.

New Horizons in Trade: South Korea’s Push for Deeper Ties with African Nations

South Korean President Yoon Suk Yeol stated, "We need to dramatically increase trade and investment to reduce the economic distance ...

How Artemis 2’s Record-Breaking Journey is Shaping the Future of Space Medicine in Asia

NASA's Artemis 2 mission sparks interest in space medicine, with South Korea's Boryung leading advancements in space-based healthcare solutions.

Tag: Biohaven

SK Biopharmaceuticals Acquires Opacalim: What This 795 Million USD Epilepsy Drug Deal Means for Patients

SK Biopharmaceuticals has acquired a new epilepsy drug candidate from Biohaven Bioscience, enhancing its portfolio in neurology.

SK Biopharmaceuticals Secures 795 Million USD License for Groundbreaking Epilepsy Drug Opacalim – What You Need to Know

SK Biopharmaceuticals acquires epilepsy drug candidate from Biohaven for 795 million USD, enhancing its global biotech portfolio.

Top News

- Our Sponsors Ad -

Follow us